価格表
在庫・価格 : 2025年09月19日 01時55分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Human VEGF R2/KDR Affinity Purified Polyclonal Ab データシート※最新のデータシートでない場合があります |
AF357-SP |
RSDアールアンドディー システムズ R&D Systems, Inc. |
25 μg | ¥28,000 | 1個 | 追加 |
在庫・価格 : 2025年09月19日 01時55分 現在
Anti-Human VEGF R2/KDR Affinity Purified Polyclonal Ab
- 商品コード:AF357-SP
- メーカー:RSD
- 包装:25μg
- 価格: ¥28,000
- 在庫:1個
使用文献
- No.: 1
-
文献情報:
Veschi V et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene 2020 01;39(5):987-1003
Veschi V et al
2020/01/01
-
備考:
Species: Xenograft, Applications: IHC-P -
参照:
- No.: 2
-
文献情報:
Dallinga MG et al. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro. Cells 2021 Apr;10(4)
Dallinga MG et al
2021/01/01
-
備考:
Species: Human, Applications: ICC -
参照:
- No.: 3
-
文献情報:
Genet G et al. Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. Nat Commun 2019 05;10(1):2350
Genet G et al
2019/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 4
-
文献情報:
Wei ST et al. Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling. Cell Death Dis 2020 May;11(5):307
Wei ST et al
2020/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 5
-
文献情報:
Fearnley GW et al. ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis. Cell Signal 2020 02;66:109481
Fearnley GW et al
2020/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 6
-
文献情報:
Tiede C et al. Affimer proteins are versatile and renewable affinity reagents. Elife 2017 06;6
Tiede C et al
2017/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 7
-
文献情報:
Shvartsman D et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol. Ther. 2014 Jul;22(7):1243-53
Shvartsman D et al
2014/01/01
-
備考:
Species: Human, Applications: Functional Assay -
参照:
- No.: 8
-
文献情報:
Giuliani N et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003 Jul;102(2):638-45
Giuliani N et al
2003/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 9
-
文献情報:
Kasza Z et al. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J. Biol. Chem. 2013 Sep;288(36):25956-63
Kasza Z et al
2013/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 10
-
文献情報:
Fiorio Pla A et al. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib. BMC Cancer 2014;14:939
Fiorio Pla A et al
2014/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 11
-
文献情報:
Liu C et al. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects.
Liu C et al
2001/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 12
-
文献情報:
Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
Usui T et al
2004/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 13
-
文献情報:
Fearnley GW et al. VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions. Mol. Biol. Cell 2014 Aug;25(16):2509-21
Fearnley GW et al
2014/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 14
-
文献情報:
Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
Orecchia A et al
2014/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 15
-
文献情報:
Goldman O et al. KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell Stem Cell 2013 Jun;12(6):748-60
Goldman O et al
2013/01/01
-
備考:
Species: Human, Applications: ICC -
参照:
- No.: 16
-
文献情報:
Minami T et al. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J. Clin. Invest. 2009 Aug;119(8):2257-70
Minami T et al
2009/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 17
-
文献情報:
Asikainen TM et al. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proc. Natl. Acad. Sci. U.S.A. 2005 Jul;102(29):10212-7
Asikainen TM et al
2005/01/01
-
備考:
Species: Human, Applications: ICC -
参照:
- No.: 18
-
文献情報:
Asikainen TM et al. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2006 Oct;291(4):L588-95
Asikainen TM et al
2006/01/01
-
備考:
Species: Primate - Papio anubis (Olive Baboon), Applications: Western Blot -
参照:
- No.: 19
-
文献情報:
Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
Cianfarani F et al
2006/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 20
-
文献情報:
Etulain J et al. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE 2014;9(4):e96402
Etulain J et al
2014/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照:
- No.: 21
-
文献情報:
Jin Y et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat. Cell Biol. 2017 Jun;19(6):639-652
Jin Y et al
2017/01/01
-
備考:
Species: Mouse, Applications: IHC -
参照:
- No.: 22
-
文献情報:
Munaut C et al. Differential expression of Vegfr-2 and its soluble form in preeclampsia. PLoS ONE 2012;7(3):e33475
Munaut C et al
2012/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 23
-
文献情報:
Gourlaouen M et al. Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells. J. Biol. Chem. 2013 Mar;288(11):7467-80
Gourlaouen M et al
2013/01/01
-
備考:
Species: Human, Applications: ICC -
参照:
- No.: 24
-
文献情報:
Lee HS et al. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am. J. Respir. Crit. Care Med. 2009 Dec;180(11):1056-67
Lee HS et al
2009/01/01
-
備考:
Species: Human, Applications: IHC -
参照:
- No.: 25
-
文献情報:
Masood R et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 2003 May;104(5):603-10
Masood R et al
2003/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 26
-
文献情報:
Heinolainen K et al. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. Circ. Res. 2017 Apr;120(9):1414-1425
Heinolainen K et al
2017/01/01
-
備考:
Species: Human, Applications: Western Blot -
参照:
- No.: 27
-
文献情報:
Eichler W et al. PEDF derived from glial MA?A?ller cells: a possible regulator of retinal angiogenesis. Exp. Cell Res. 2004 Sep;299(1):68-78
Eichler W et al
2004/01/01
-
備考:
Species: Human, Applications: Neutralization -
参照: